Levoketoconazole
id:
levoketoconazole-278-5387653
title:
Levoketoconazole
text:
Levoketoconazole, sold under the brand name Recorlev, is a steroidogenesis inhibitor that is used for the treatment of Cushing's syndrome. Levoketoconazole was approved for medical use in the United States in December 2021. Levoketoconazole is the levorotatory or (2S,4R) enantiomer of ketoconazole, and it is an inhibitor of the enzymes CYP11B1 (11β-hydroxylase), CYP17A1 (17α-hydroxylase/17,20-lyase), and CYP21A2 (21-hydroxylase). It inhibits glucocorticoid biosynthesis and hence circulating leve
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Levoketoconazole
date created:
date modified:
2023-12-03T11:08:04Z
main entity:
{"identifier":"Q27120779","url":"https://www.wikidata.org/entity/Q27120779"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/b1/Levoketoconazole.svg","width":907,"height":385}
fields total:
13
integrity:
15